Ten years ago this town was bustling with life and activity every day after church service. Now we're lucky if a handful of people show up, let alone feel safe walking home.

GlaxoSmithKline's latest drug trial results for Mo-Rez are promising, cutting tumors in 60% of patients suffering from ovarian and womb cancers. It sounds like good news on the surface, but I've lived here 40 years and know there’s more to it than that.

Back when people still trusted big pharma, a drug like Mo-Rez might have made headlines for its humanitarian potential. But after decades of seeing profits come before patients, even positive results raise eyebrows around these parts. What will be the price tag?

The pattern repeats itself every time: a breakthrough drug announced with great fanfare, followed by a price that leaves most families in despair. Last year's heart disease treatment from Pfizer was hailed as revolutionary too, until it cost more than a new car.

Conservatives here remember when prescription drugs were accessible to everyone, not just the wealthy or insured. But every passing administration seems to erode that trust further.

I know some might argue this is an overreaction, but consider: how many families will be priced out of hope and healing?